{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T05:51:33Z","timestamp":1769579493519,"version":"3.49.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2004,4,27]],"date-time":"2004-04-27T00:00:00Z","timestamp":1083024000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1038\/sj.bjc.6601830","type":"journal-article","created":{"date-parts":[[2004,6,18]],"date-time":"2004-06-18T14:14:09Z","timestamp":1087568049000},"page":"1961-1968","source":"Crossref","is-referenced-by-count":30,"title":["Cysteine proteinase inhibitor cystatin C in squamous cell carcinoma of the head and neck: relation to prognosis"],"prefix":"10.1038","volume":"90","author":[{"given":"P","family":"Strojan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Oblak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Svetic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"\u0160mid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Kos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,4,27]]},"reference":[{"key":"BF6601830_CR1","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1055\/s-0038-1635335","volume":"23","author":"U Abel","year":"1984","unstructured":"Abel U, Berger J, Wiebelt H (1984) Critlevel: an exploratory procedure for the evaluation of quantitative prognostic factors. Methods Inform Med 23: 154\u2013156","journal-title":"Methods Inform Med"},{"key":"BF6601830_CR2","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1042\/bj2730621","volume":"273","author":"M Abrahamson","year":"1991","unstructured":"Abrahamson M, Mason RW, Hansson H, Buttle DJ, Grubb A, Ohlsson K (1991) Human cystatin C: role of the N-terminal segment in the inhibition of human cysteine proteinases and in its inactivation by leucocyte elastase. Biochem J 273: 621\u2013626","journal-title":"Biochem J"},{"key":"BF6601830_CR3","volume-title":"International Histological Classification of Tumours No 2: Histological Typing of Breast Tumours","author":"JG Azzopardi","year":"1981","unstructured":"Azzopardi JG, Chepizk OF, Hartman WH (1981) International Histological Classification of Tumours No 2: Histological Typing of Breast Tumours. Geneva: World Health Organization"},{"key":"BF6601830_CR4","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein\u2013dye binding. Anal Biochem 72: 248\u2013254","journal-title":"Anal Biochem"},{"key":"BF6601830_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1146\/annurev.physiol.59.1.63","volume":"59","author":"HA Chapman","year":"1997","unstructured":"Chapman HA, Riese RJ, Shi GP (1997) Emerging roles for cysteine proteinases in human biology. Annu Rev Physiol 59: 63\u201388","journal-title":"Annu Rev Physiol"},{"key":"BF6601830_CR6","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3109\/14756369909036552","volume":"14","author":"N Cimerman","year":"1999","unstructured":"Cimerman N, Trstenjak Prebanda M, Turk B, Popovi\u010d T, Dolenc I, Turk V (1999) Interaction of cystatin C variants with papain and human cathepsins B, H and L. J Enzyme Inhibition 14: 167\u2013174","journal-title":"J Enzyme Inhibition"},{"key":"BF6601830_CR7","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1002\/ijc.2910520425","volume":"52","author":"O Corticchiato","year":"1992","unstructured":"Corticchiato O, Cajot JF, Abrahamson M, Chan SJ, Keppler D (1992) Cystatin C and cathepsin B in human colon carcinoma: expression by cell lines and matrix degradation. Int J Cancer 52: 645\u2013652","journal-title":"Int J Cancer"},{"key":"BF6601830_CR8","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1002\/(SICI)1097-0215(19991112)83:4<526::AID-IJC15>3.0.CO;2-M","volume":"83","author":"S Coulibaly","year":"1999","unstructured":"Coulibaly S, Schwihla H, Abrahamson M, Albini A, Cerni C, Clark JL, Ng KM, Katunuma N, Schlappack O, Gl\u00f6ssl J, Mach L (1999) Modulation of invasive properties of murine squamous carcinoma cells by heterologous expression of cathepsin B and cystatin C. Int J Cancer 83: 526\u2013531","journal-title":"Int J Cancer"},{"key":"BF6601830_CR9","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"187","author":"DR Cox","year":"1972","unstructured":"Cox DR (1972) Regression models and life tables. J Roy Stat Soc 187: 187\u2013220","journal-title":"J Roy Stat Soc"},{"key":"BF6601830_CR10","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/00008390-199908000-00005","volume":"9","author":"JL Cox","year":"1999","unstructured":"Cox JL, Sexton PS, Green TJ, Darmani NA (1999) Inhibition of B16 melanoma metastasis by overexpression of the cysteine proteinase inhibitor cystatin C. Melanoma Res 9: 369\u2013374","journal-title":"Melanoma Res"},{"key":"BF6601830_CR11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/978-1-4757-9613-1_34","volume":"421","author":"E Ebert","year":"1997","unstructured":"Ebert E, Werle B, J\u00fclke B, Kopitar-Jerala N, Kos J, Lah T, Abrahamson M, Spiess E, Ebert W (1997) Expression of cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in human lung tumor tissue. Adv Exp Med Biol 421: 259\u2013265","journal-title":"Adv Exp Med Biol"},{"key":"BF6601830_CR12","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1074\/jbc.271.3.1314","volume":"271","author":"I Ekiel","year":"1996","unstructured":"Ekiel I, Abrahamson M (1996) Folding-related dimerization of human cystatin C. J Biol Chem 271: 1314\u20131321","journal-title":"J Biol Chem"},{"key":"BF6601830_CR13","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1200\/JCO.1998.16.3.1013","volume":"16","author":"JA Foekens","year":"1998","unstructured":"Foekens JA, Kos J, Peters HA, Kra\u0161ovec M, Look MP, Cimerman N, Meijer-van Gelder ME, Henzen-Logmans SC, van Putten WLJ, Klijn JGM (1998) Prognostic significance of cathepsins B and L in primary human breast cancer. J Clin Oncol 16: 1013\u20131021","journal-title":"J Clin Oncol"},{"key":"BF6601830_CR14","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1078\/0344-0338-00044","volume":"197","author":"A Gaumann","year":"2001","unstructured":"Gaumann A, Hansen T, K\u00f6hler HH, Kommoss F, Mann W, Maurer J, Kirkpatrick CJ, Kriegsmann J (2001) The expression of cathepsins in osteoclast-like giant cells of an anaplastic thyroid carcinoma with tracheal perforation. Pathol Res Pract 197: 257\u2013262","journal-title":"Pathol Res Pract"},{"key":"BF6601830_CR15","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/modpathol.3880309","volume":"14","author":"T Hansen","year":"2001","unstructured":"Hansen T, Petrow PK, Gaumann A, Keyszer GM, Otto M, Kirkpatrick CJ, Kriegsmann J (2001) Expression of cysteine proteinases cathepsins B and K and of cysteine proteinase inhibitor cystatin C in giant cell tumor of tendon sheath. Mod Pathol 14: 318\u2013324","journal-title":"Mod Pathol"},{"key":"BF6601830_CR16","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/S0046-8177(99)90094-1","volume":"30","author":"K Hirai","year":"1999","unstructured":"Hirai K, Yokoyama M, Asano G, Tanaka S (1999) Expression of cathepsin B and cystatin C in human colorectal cancer. Hum Pathol 30: 680\u2013686","journal-title":"Hum Pathol"},{"key":"BF6601830_CR17","first-page":"332","volume":"52","author":"CG Huh","year":"1999","unstructured":"Huh CG, H\u00e5kansson K, Nathanson CM, Thorgeirsson UP, Jonsson N, Grubb A, Abrahamson M, Karlsson S (1999) Decreased metastatic spread in mice homozygous for a null allele of the cystatin C protease inhibitor gene. J Clin Pathol: Mol Pathol 52: 332\u2013340","journal-title":"J Clin Pathol: Mol Pathol"},{"key":"BF6601830_CR18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1006\/excr.1999.4455","volume":"248","author":"M Jaattela","year":"1999","unstructured":"Jaattela M (1999) Escaping cell death: survival proteins in cancer. Exp Cell Res 248: 30\u201343","journal-title":"Exp Cell Res"},{"key":"BF6601830_CR19","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observation. J Am Stat Assoc 53: 457\u2013481","journal-title":"J Am Stat Assoc"},{"key":"BF6601830_CR20","first-page":"77","volume":"5","author":"H Knoch","year":"1994","unstructured":"Knoch H, Werle B, Ebert W, Spiess E (1994) Imbalance between cathepsin B and cysteine proteinase inhibitors is of prognostic significance in human lung cancer. Int J Oncol 5: 77\u201385","journal-title":"Int J Oncol"},{"key":"BF6601830_CR21","doi-asserted-by":"publisher","first-page":"8705","DOI":"10.1038\/sj.onc.1205949","volume":"21","author":"SD Konduri","year":"2002","unstructured":"Konduri SD, Yanamandra N, Siddique K, Joseph A, Dinh DH, Olivero WC, Gujrati M, Kouraklis G, Swaroop A, Kyritsis AP, Rao JS (2002) Modulation of cystatin C expression impairs the invasive and tumorigenic potential of human glioblastoma cells. Oncogene 21: 8705\u20138712","journal-title":"Oncogene"},{"key":"BF6601830_CR22","first-page":"505","volume":"6","author":"J Kos","year":"2000","unstructured":"Kos J, Kra\u0161ovec M, Cimerman N, Nielsen HJ, Christensen IJ, Br\u00fcnner N (2000a) Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis. Clin Cancer Res 6: 505\u2013511","journal-title":"Clin Cancer Res"},{"key":"BF6601830_CR23","first-page":"1349","volume":"5","author":"J Kos","year":"1998","unstructured":"Kos J, Lah TT (1998) Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer (review). Oncol Rep 5: 1349\u20131361","journal-title":"Oncol Rep"},{"key":"BF6601830_CR24","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1177\/172460080001500116","volume":"15","author":"J Kos","year":"2000","unstructured":"Kos J, Werle B, Lah T, Brunner N (2000b) Cysteine proteinases and their inhibitors in extracellular fluids: markers for diagnosis and prognosis in cancer. Int J Biol Markers 15: 84\u201389","journal-title":"Int J Biol Markers"},{"key":"BF6601830_CR25","first-page":"33","volume":"22","author":"R Kothapalli","year":"2003","unstructured":"Kothapalli R, Bailey RD, Kusmartseva I, Mane S, Epling-Burnette PK, Loughran TS (2003) Constitutive expression of cytotoxic proteases and down-regulation of protease inhibitors in LGL leukemia. Int J Oncol 22: 33\u201339","journal-title":"Int J Oncol"},{"key":"BF6601830_CR26","first-page":"318","volume":"45","author":"E K\u0159epela","year":"1998","unstructured":"K\u0159epela E, Proch\u00e1zka J, K\u00e1rov\u00e1 B, \u010cerm\u00e1k J, Roubkov\u00e1 H (1998) Cysteine proteases and cysteine protease inhibitors in non-small cell lung cancer. Neoplasma 45: 318\u2013331","journal-title":"Neoplasma"},{"key":"BF6601830_CR27","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/ijc.2910610109","volume":"61","author":"E K\u0159epela","year":"1995","unstructured":"K\u0159epela E, Proch\u00e1zka J, Myna\u0159\u00edkov\u00e1 H, K\u00e1rov\u00e1 B, Pol\u00e1k J, \u010cerm\u00e1k J, Roubkov\u00e1 H (1995) Multiple forms of cathepsin B in human lung cancer. Int J Cancer 61: 44\u201353","journal-title":"Int J Cancer"},{"key":"BF6601830_CR28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0304-4165(89)90144-X","volume":"993","author":"TT Lah","year":"1989","unstructured":"Lah TT, Clifford JL, Helmer KM, Day NA, Moin K, Honn KV, Crissman JD, Sloane BF (1989) Inhibitory properties of low molecular mass cysteine proteinase inhibitors from human sarcoma. Biochim Biophys Acta 993: 63\u201373","journal-title":"Biochim Biophys Acta"},{"key":"BF6601830_CR29","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/ijc.2910500109","volume":"50","author":"TT Lah","year":"1992","unstructured":"Lah TT, Kokalj-Kunovar M, \u0160trukelj B, Punger\u010dar J, Barli\u010d-Magajna D, Drobni\u010d-Ko\u0161orok M, Kastelic L, Babnik J, Golouh R, Turk V (1992) Stefins and lysosomal cathepsins B, L and D in human breast carcinoma. Int J Cancer 50: 36\u201344","journal-title":"Int J Cancer"},{"key":"BF6601830_CR30","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/BF02907801","volume":"3","author":"TT Lah","year":"1997","unstructured":"Lah TT, Kos J, Blejec A, Frkovi\u010d-Georgio S, Golouh R, Vrhovec I, Turk V (1997) The expression of lysosomal proteinases and their inhibitors in breast cancer: possible relationship to prognosis of the disease. Pathol Oncol Res 3: 89\u201399","journal-title":"Pathol Oncol Res"},{"key":"BF6601830_CR31","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/0009-9120(94)90024-8","volume":"27","author":"H Lal","year":"1994","unstructured":"Lal H (1994) Biochemical studies in head and neck cancers. Clin Biochem 27: 235\u2013295","journal-title":"Clin Biochem"},{"key":"BF6601830_CR32","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/0014-5793(91)80295-E","volume":"280","author":"B Lenar\u010di\u010d","year":"1991","unstructured":"Lenar\u010di\u010d B, Kra\u0161ovec M, Ritonja A, Olafsson I, Turk V (1991) Inactivation of human cystatin C and kininogen by human cathepsin D. FEBS Lett 280: 211\u2013215","journal-title":"FEBS Lett"},{"key":"BF6601830_CR33","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s004010050644","volume":"93","author":"H Lignelid","year":"1997","unstructured":"Lignelid H, Collins VP, Jacobsson B (1997) Cystatin C and transthyretin expression in normal and neoplastic tissues of the human brain and pituitary. Acta Neuropathol 93: 494\u2013500","journal-title":"Acta Neuropathol"},{"key":"BF6601830_CR34","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/BF01606878","volume":"421","author":"H Lignelid","year":"1992","unstructured":"Lignelid H, Jacobsson B (1992) Cystatin C in the human pancreas and gut: an immunohistochemical study of normal and neoplastic tissues. Wirchows Archiv Pathol Anat 421: 491\u2013495","journal-title":"Wirchows Archiv Pathol Anat"},{"key":"BF6601830_CR35","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1093\/jnci\/94.2.116","volume":"94","author":"MP Look","year":"2002","unstructured":"Look MP, van Putten WLJ, Duffy MJ, Harbeck N, Christensen IJ, Thomssen C, Kates R, Spyratos F, Fern\u00f6 M, Eppenberger-Castori S, Sweep CGJF, Ulm K, Peyrat JP, Martin PM, Magdelenat H, Br\u00fcnner N, Duggan C, Lisboa BW, Bendahl PO, Quillien V, Daver A, Ricolleau G, Meijer-van Gelder ME, Manders P, Fiets WE, Blankenstein MA, Bro\u00ebt P, Romain S, Daxenbichler G, Windbichler G, Cufer T, Borstnar S, Kueng W, Beex LVAM, Klijn JGM, O\u2019Higgins N, Eppenberger U, J\u00e4nicke F, Schmitt M, Foekens JA (2002) Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients. J Natl Cancer Inst 94: 116\u2013128","journal-title":"J Natl Cancer Inst"},{"key":"BF6601830_CR36","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/(SICI)1097-4652(199712)173:3<423::AID-JCP15>3.0.CO;2-C","volume":"173","author":"GS Merz","year":"1997","unstructured":"Merz GS, Benedikz E, Schwenk V, Johansen TE, Vogel LK, Rushbrook JI, Wisniewski HM (1997) Human cystatin C forms an inactive dimer during intracellular trafficking in transfected CHO cells. J Cell Physiol 173: 423\u2013432","journal-title":"J Cell Physiol"},{"key":"BF6601830_CR37","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1258\/0004563021901847","volume":"39","author":"DJ Newman","year":"2002","unstructured":"Newman DJ (2002) Cystatin C. Ann Clin Biochem 39: 89\u2013104","journal-title":"Ann Clin Biochem"},{"key":"BF6601830_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/bjc.1977.1","volume":"35","author":"R Peto","year":"1977","unstructured":"Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG (1977) Design and analysis of randomized clinical trials requiring prolonged observation of each patients. II. Analysis and examples. Br J Cancer 35: 1\u201339","journal-title":"Br J Cancer"},{"key":"BF6601830_CR39","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1023\/A:1012584429734","volume":"1","author":"ON Poteryaeva","year":"2001","unstructured":"Poteryaeva ON, Falameeva OV, Zhanaeva SY, Svechnikova IG, Korolenko TA, Kaledin VI (2001) Role of cystatin C and cysteine proteinases in the development of mouse LS-lymphosarcoma. Bull Exp Biol Med 1: 675\u2013677","journal-title":"Bull Exp Biol Med"},{"key":"BF6601830_CR40","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/1097-0347(200102)23:2<147::AID-HED1010>3.0.CO;2-#","volume":"23","author":"H Quon","year":"2001","unstructured":"Quon H, Liu FF, Cummings BJ (2001) Potential molecular prognostic markers in head and neck squamous cell carcinoma. Head Neck 23: 147\u2013159","journal-title":"Head Neck"},{"key":"BF6601830_CR41","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/00008390-199704000-00002","volume":"7","author":"PS Sexton","year":"1997","unstructured":"Sexton PS, Cox JL (1997) Inhibition of motility and invasion of B16 melanoma by the overexpression of cystatin C. Melanoma Res 7: 97\u2013101","journal-title":"Melanoma Res"},{"key":"BF6601830_CR42","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/B978-0-12-564499-0.50016-X","volume-title":"Biochemical and Molecular Aspects of Selected Cancers","author":"BF Sloane","year":"1994","unstructured":"Sloane BF, Moin K, Lah TT (1994) Regulation of lysosomal endopeptidases in malignant neoplasia. In Biochemical and Molecular Aspects of Selected Cancers, Pretlow TG, Pretlow TP (eds). pp 411\u2013472. NewYork: Academic Press"},{"key":"BF6601830_CR43","volume-title":"TNM Classification of Malignant Tumours. International Union Against Cancer (UICC)","author":"LH Sobin","year":"1997","unstructured":"Sobin LH, Wittekind Ch (1997) TNM Classification of Malignant Tumours. International Union Against Cancer (UICC). New York: Wiley-Liss"},{"key":"BF6601830_CR44","first-page":"1052","volume":"6","author":"P Strojan","year":"2000","unstructured":"Strojan P, Budihna M, \u0160mid L, Svetec B, Vrhovec I, Kos J, \u0160krk J (2000) Prognostic significance of cysteine proteinases cathepsins B and L and their endogenous inhibitors stefins A and B in patients with squamous cell carcinoma of the head and neck. Clin Cancer Res 6: 1052\u20131062","journal-title":"Clin Cancer Res"},{"key":"BF6601830_CR45","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1097\/00006123-200103000-00029","volume":"48","author":"T Strojnik","year":"2001","unstructured":"Strojnik T, \u017didanik B, Kos J, Lah TT (2001) Cathepsins B and L are markers in clinically invasive types of meningiomas. Neurosurgery 48: 598\u2013605","journal-title":"Neurosurgery"},{"key":"BF6601830_CR46","first-page":"3493","volume":"61","author":"AM Szpaderska","year":"2001","unstructured":"Szpaderska AM, Frankfater A (2001) An intracellular form of cathepsin B contributes to invasiveness in cancer. Cancer Res 61: 3493\u20133500","journal-title":"Cancer Res"},{"key":"BF6601830_CR47","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s005950170126","volume":"31","author":"M Yano","year":"2001","unstructured":"Yano M, Hirai K, Naito Z, Yokoyama M, Ishiwata T, Shiraki Y, Inokuchi M, Asano G (2001) Expression of cathepsin B and cystatin C in human breast cancer. Surg Today 31: 385\u2013389","journal-title":"Surg Today"},{"key":"BF6601830_CR48","first-page":"27","volume":"7","author":"K Yoshimura","year":"2000","unstructured":"Yoshimura K, Tsuchida T, Kawamoto K (2000) Expression of cathepsin B and cystatin C in the human adenohypophysis and in pituitary adenomas. Oncol Rep 7: 27\u201331","journal-title":"Oncol Rep"},{"key":"BF6601830_CR49","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1515\/bchm.2001.382.5.805","volume":"382","author":"I Zore","year":"2001","unstructured":"Zore I, Kra\u0161ovec M, Cimerman N, Kuhelj R, Werle B, Nielsen HJ, Br\u00fcnner N, Kos J (2001) Cathepsin B\/cystatin C complex levels in sera from patients with lung and colorectal cancer. Biol Chem 382: 805\u2013810","journal-title":"Biol Chem"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6601830.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6601830","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6601830.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T16:27:25Z","timestamp":1734452845000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6601830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4,27]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["BF6601830"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6601830","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,4,27]]}}}